|
|
|
|
| LEADER |
01571nam a22003015i 4500 |
| 001 |
000291009 |
| 005 |
20210602160343.0 |
| 007 |
cr nn 008mamaa |
| 008 |
110910s2011 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781461406501
|
| 024 |
7 |
|
|a 10.1007/978-1-4614-0650-1
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Sphingolipids and Metabolic Disease /
|c edited by L. Ashley Cowart.
|
| 250 |
|
|
|a 1st ed. 2011.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2011.
|
| 300 |
|
|
|a XVIII, 148 p. 26 illus. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Advances in Experimental Medicine and Biology,
|v 721
|
| 505 |
0 |
|
|a Sphingolipid Metabolism and Analysis in Metabolic Disease -- Sphingolipids and Cardiovascular Diseases: Lipoprotein Metabolism, Atherosclerosis and Cardiomyopathy -- Heart Sphingolipids in Health and Disease -- Blood Sphingolipids in Homeostasis and Pathobiology -- Adipose Tissue and Ceramide Biosynthesis in the Pathogenesis of Obesity -- Sphingolipids and Hepatic Steatosis -- Glycosphingolipids and Insulin Resistance -- Glyco Sphingolipids and Kidney Disease -- Sphingolipid Synthetic Pathways are Major Regulators of Lipid Homeostasis.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Metabolic diseases.
|
| 650 |
1 |
4 |
|a Molecular Medicine.
|
| 650 |
2 |
4 |
|a Metabolic Diseases.
|
| 700 |
1 |
|
|a Cowart, L. Ashley.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|